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Summary
Components of intracellular signaling that mediate
the stimulation-dependent recycling of integrins are
being identified, but key transport effectors that are
the ultimate downstream targets remain unknown.
ACAP1 has been shown recently to function as a
transport effector in the cargo sorting of transferrin
receptor (TfR) that undergoes constitutive recycling.
We now show that ACAP1 also participates in the reg-
ulated recycling of integrin 1 to control cell migra-
tion. However, in contrast to TfR recycling, the role of
ACAP1 in 1 recycling requires its phosphorylation
by Akt, which is, in turn, regulated by a canonical sig-
naling pathway. Disrupting the activities of either
ACAP1 or Akt, or their assembly with endosomal 1,
inhibits 1 recycling and cell migration. These find-
ings advance an understanding of how integrin re-
cycling is achieved during cell migration, and also
address a basic issue of how intracellular signaling
can interface with transport to achieve regulated re-
cycling.
Introduction
Regulated endocytic recycling involves extracellular
stimuli transmitted through intracellular signaling cas-
cades to stimulate internal transport at endosomal
compartments. An example of this process is the stim-
ulation-dependent recycling of integrin β1 (Ivaska et al.,
2002; Powelka et al., 2004). Integrin recycling is thought
to play an important role in cell migration by redistribut-
ing integrins from the retracting edges to the migrating
front (Bretscher, 1992; Lawson and Maxfield, 1995). Key
components of intracellular signaling that participate in
integrin recycling are being identified (Ivaska et al.,
2002; Ng et al., 1999; Roberts et al., 2004; Woods et al.,
2004). However, the identity of key transport effectors
that represent the ultimate downstream targets in this
process remains unknown.
The ADP-Ribosylation Factor (ARF) family of small
GTPases initiates intracellular transport by regulating
the recruitment of coat proteins and other cargo-sort-
ing adaptors from the cytosol to membrane (Nie et al.,
2003). The GTPase-activating proteins (GAPs) for these
small GTPases in the better-characterized transport
pathways have been shown to function not only as*Correspondence: vhsu@rics.bwh.harvard.edunegative upstream regulators of ARFs, but also as their
effectors, by being components of coat complexes
(Kuehn et al., 1998; Yang et al., 2002). Taking advantage
of this insight, we have shown recently that ACAP1, a
previously identified GAP for ARF6 (Jackson et al., 2000),
also functions as an effector in cargo sorting at the re-
cycling endosome for the recycling of transferrin recep-
tor (TfR) from this compartment (Dai et al., 2004). How-
ever, TfR is an example of a constitutively recycled
cargo protein, and, thus, whether ACAP1 also partici-
pates in the cargo sorting of regulated recycling pro-
teins remains unknown.
We now identify ACAP1 as a key transport effector in
the stimulation-dependent recycling of integrin β1 and
also elucidate how ACAP1 functions in this example of
regulated recycling.
Results
ACAP1 Colocalizes with Endosomal 1
and Is Critical for 1 Recycling
Using an antibody binding technique, we previously
showed that endocytic β1 accumulated at the recycling
endosome under the starvation condition, and then re-
cycled upon acute stimulation (Powelka et al., 2004).
An alternate biotinylation-based technique showed a
similar result (Powelka et al., 2004), indicating that the
bound antibody did not influence the endocytic behav-
ior of β1. Thus, using the antibody-based technique, we
first determined whether β1 arrested at the recycling
endosome in starved cells colocalized with ACAP1. As
done previously to reveal the membrane distribution of
ACAP1, ACAP1-transfected cells were permeabilized
to remove the cytosol (Dai et al., 2004). Upon examina-
tion by confocal microscopy, we found that the mem-
brane pool of ACAP1 colocalized extensively with β1 at
the recycling endosome (Figure 1A).
To test whether this endosomal ACAP1 played a role
in β1 recycling, we first examined whether β1 recycling
was affected upon knocking down ACAP1. Using a
plasmid that was shown previously to express a small
interfering RNA (siRNA) against ACAP1 (Dai et al., 2004),
we confirmed its efficient knockdown of endogenous
ACAP1 (Figure S1A; see the Supplemental Data avail-
able with this article online). In this setting, β1 recycling
was also inhibited (Figure 1B). To test whether this ef-
fect of the siRNA was specific against endogenous
ACAP1, we performed a rescue experiment. In the stretch
of the ACAP1 sequence targeted by the siRNA, four
bases at the degenerate codon positions were mutated
so that the amino acid sequence remained unchanged.
When HeLa cells that stably expressed this form of
ACAP1 were again treated with the siRNA, we found
that total detectable ACAP1 was no longer significantly
reduced (Figure 1C), and inhibition of β1 recycling that
had been induced by the siRNA was also reversed (Fig-
ure 1D).
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(A) Membrane bound ACAP1 colocalizes extensively with endosomal β1. HeLa cells transiently transfected with ACAP1 were starved, and
then antibody-bound surface β1 was allowed to accumulate at the recycling endosome. Cells were permeabilized and then fixed for confocal
microscopy; bar, 10 m.
(B) Knocking down of ACAP1 inhibits β1 recycling. HeLa cells, either transfected with siRNA against ACAP1 or mock transfected, were
subjected to the recycling assay. The level of internal β1 at the times indicated was quantified, and then calculated as a percentage of that
at the initial time point. The mean of this calculated value from three independent experiments is shown with standard error.
(C) A rescue form of ACAP1 is resistant to siRNA against endogenous ACAP1. HeLa cells that stably expressed the wild-type or rescue form
of ACAP1 were treated with siRNA directed against the wild-type sequence of ACAP1.
(D) Expression of a rescue ACAP1 overcomes the inhibition of β1 recycling induced by siRNA against endogenous ACAP1. HeLa cells that
stably expressed a rescue form of ACAP1 were treated with siRNA against endogenous ACAP1, and β1 recycling was examined in these
cells as described in (B).Stimulation-Dependent Association of ACAP1
with Endosomal 1
As ACAP1 had been shown recently to be critical for
TfR recycling through a novel function in cargo sorting
that entailed its association with TfR (Dai et al., 2004),
we next examined whether ACAP1 also associated with
β1 at the recycling endosome. Immunoprecipitation of
endosomal β1 (gathered at the recycling endosome in
starved cells) revealed a stimulation-dependent associ-
ation with ACAP1 in both transiently transfected (Figure
2A) and untransfected cells (Figure 2B), indicating that
ectopically expressed and endogenous ACAP1 be-
haved similarly in their stimulation-dependent associa-
tion with endosomal β1. As control, endosomal β1 did
not associate with other surface proteins that un-
derwent recycling (Figure 2C), such as TfR and the
MHC class I molecule.
Because TfR is representative of a constitutively re-
cycling cargo protein that has been shown previously
to interact with ACAP1 at the recycling endosome (Dai
et al., 2004), we also examined this interaction in re-
sponse to stimulation. As before (Dai et al., 2004), bio-
tin-labeled transferrin was bound to surface TfR and
then accumulated at the recycling endosome. Upon
isolation with streptavidin beads, we found that the as-
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βociation of endosomal TfR with ACAP1 was not changed
ignificantly by stimulation (Figure 2D).
esidues in ACAP1 Critical
or Its Association with 1
s the results thus far suggested the possibility that the
timulation-dependent association of endosomal β1
ith ACAP1 could explain why ACAP1 was critical for
1 recycling, we next sought to test this possibility by
lucidating how stimulation regulated this association.
s different kinase activities have been identified to
articipate in integrin recycling (Ivaska et al., 2002;
oberts et al., 2004; Woods et al., 2004), we first exam-
ned whether β1 and/or ACAP1 were phosphorylated
pon acute stimulation. After orthophosphate radiola-
eling, phosphorylation of endosomal β1 was not de-
ectable, in either the starved or stimulated condition
Figure 3A). In contrast, phosphorylation of the EGF re-
eptor (EGFR) as control (Figure 3A), and that of ACAP1
Figure 3B), was readily seen.
However, we also noted that the total phosphoryla-
ion of ACAP1 did not change significantly upon stimu-
ation (Figure 3B). In considering how this observation
ould be reconciled with a potential role for ACAP1 in
1 recycling, we considered the possibility that phos-
Integrin Recycling through ACAP1 Phosphorylation
665Figure 2. Stimulation-Dependent Association of ACAP1 with Endo-
somal β1
(A) Stimulation enhances the association of transfected ACAP1
with endosomal β1. HeLa cells transiently transfected with ACAP1
were either starved or stimulated, followed by immunoprecipitation
for endosomal β1 and then immunoblotting for ACAP1. As control,
the same procedure was also performed on cells whose surface β1
was not bound with antibody.
(B) Stimulation enhances the association of endogenous ACAP1
with endosomal β1. The same coprecipitation study as described
in (A) was performed on untransfected HeLa cells.
(C) Endosomal β1 does not associate with other recycling proteins.
The same coprecipitation study as described in (A) was performed
on untransfected HeLa cells, and then immunoblotted for proteins
as indicated.
(D) Stimulation does not enhance the interaction between endoso-
mal TfR and ACAP1. HeLa cells transiently transfected with ACAP1
were starved, and then surface bound transferrin (Tf) that was bio-
tinylated was allowed to accumulate at the recycling endosome.
Cells were then continued in starvation or acutely stimulated with
20% serum. After cell lysis, streptavidin bound beads were used to
bind biotinylated Tf, followed by immunoblotting for proteins as in-
dicated.phorylation at selective residues may provide the ex-
planation. Using an algorithm that predicts potential
phosphorylation sites based on consensus sites for the
known kinases (Yaffe et al., 2001), we identified 12 can-
didate sites in ACAP1 (Figure 3C). To determine which
of these sites may be relevant for β1 recycling, we mu-
tated each serine/threonine residue individually to ala-
nine and tyrosine to phenylalanine, and we then exam-
ined whether the point mutation affected the ability of
ACAP1 to interact with endosomal β1. Two point muta-
tions, serine at position 554 (S554) or serine at position
724 (S724), were found to reduce the stimulation-
dependent association of ACAP1 with β1 (Figure 3D).
We also examined the effect of mutating the serine resi-
dues to aspartate, which could mimic the effect of
phosphorylation. These mutations resulted in enhanced
interaction between ACAP1 and β1, so that it was no
longer stimulation dependent (Figure 3E).
To elucidate further how mutations at key residues in
ACAP1 regulated its interaction with endosomal β1, we
considered two mechanistic possibilities. As ACAP1
needs to be recruited from the cytosol onto endosomal
membrane to interact with the membrane bound β1,one possibility was that the mutations affected this re-
cruitment step. Alternatively, the mutations could affect
the ability of ACAP1 to interact directly with β1, after
ACAP1 has been recruited onto the membrane. To test
for the first possibility, we generated HeLa cells that
stably expressed the different ACAP1 mutants. Cells
that stably expressed the wild-type form were also gen-
erated as a control to rule out the possibility that the
transfection protocol itself contributed to any potential
changes noted. To distinguish the transfected ACAP1
from its endogenous pool, the transfected forms were
epitope tagged, as this modification had been shown
previously not to affect the different functions of ACAP1
(Dai et al., 2004). After cell permeabilization to remove
the cytosol, we found that the levels of the different
ACAP1 mutants on membrane were similar regardless
of stimulation (Figure 4A). Thus, we concluded that the
mutations did not have a significant effect on the re-
cruitment of ACAP1 from the cytosol to membrane.
To test for the alternate possibility that these muta-
tions on ACAP1 affected its direct interaction with β1,
we used a pull-down approach, as done previously to
examine the direct interaction of ACAP1 with other re-
cycling cargo proteins (Dai et al., 2004). When the cyto-
plasmic domain of β1 was fused to glutathione-s-trans-
ferase (GST) and then incubated with the different
mutants as recombinant proteins, we found that the
aspartate mutants supported an enhanced interaction
as compared to that of the alanine mutants (Figure 4B).
Strikingly, no significant difference was noted when
these different point mutants were incubated with
beads that contained the cytoplasmic domain of TfR
fused to GST (Figure 4C). Thus, we concluded that mu-
tations at the two key residues in ACAP1 regulated its
direct interaction with β1.
The Association of ACAP1 with Endosomal 1
Is Responsible for 1 Recycling
The noted effects of the ACAP1 mutants also allowed
us to test more definitively whether the association of
ACAP1 with endosomal β1 was responsible for β1 re-
cycling. First, with respect to the alanine point mutants,
we noted that their distribution appeared to be similar
to that of the wild-type (compare Figure S2A and Figure
1A). This observation, together with the above-described
finding that they could not interact efficiently with β1,
suggested that they would act in a dominant-negative
manner to inhibit β1 recycling by preventing endoge-
nous ACAP1 from properly engaging β1 at the recycling
endosome. Indeed, whereas β1 in cells that stably ex-
pressed the wild-type ACAP1 recycled in a stimulation-
dependent manner, as seen in untransfected cells, this
recycling in cells that stably expressed the alanine mu-
tants was inhibited (Figure 4D).
Conversely, the prediction for the aspartate muta-
tions of ACAP1, which induced the enhanced associa-
tion with β1 even under the starvation condition, was
that the expression of these point mutants should render
β1 recycling constitutive, being no longer dependent on
cell stimulation. However, because this situation would
prevent the accumulation of endosomal β1, which was
needed as the starting point for the biochemical assay
to measure β1 recycling quantitatively, we used pri-
Developmental Cell
666Figure 3. Phosphorylation at Critical Resi-
dues in ACAP1 Regulates Its Association
with β1 to Modulate β1 Recycling
(A) Integrin β1 is not phosphorylated in either
the starved or stimulated condition. Starved
HeLa cells were labeled with 32P-orthophos-
phate and then stimulated with 20% serum
for the times indicated. Cells were then lysed
and immunoprecipitated for proteins as indi-
cated, followed by autoradiography (upper
panel); note that the arrow for β1 indicates
where it should migrate in the gel. Immu-
noblotting (lower panel) shows similar levels
of β1 analyzed.
(B) ACAP1 is phosphorylated in both the
starved and stimulated condition. Starved
HeLa cells were transiently transfected with
ACAP1 and then subjected to the same or-
thophosphate labeling as indicated in (A).
Cells were then lysed and immunoprecip-
itated for ACAP1, followed by autoradiog-
raphy (upper panel). Immunoblotting (lower
panel) showed similar levels of ACAP1 ana-
lyzed.
(C) Potential sites of phosphorylation in
ACAP1 based on an algorithm that detects consensus sites of known kinases. The different serine, threonine, and tyrosine sites that are
potentially phosphorylated by known kinases by using a prediction algorithm are indicated, with the different functional domains of ACAP1
also shown.
(D) Point mutation to alanine at S554 or S724 in ACAP1 prevents its stimulation-enhanced association with endosomal β1. HeLa cells were
transiently transfected with different point mutants of ACAP1. Endosomal β1 was then immunoprecipitated from starved or stimulated cells.
The level of ACAP1 detected on beads was normalized to the level of β1, and this normalized value was then calculated as a percentage of
that derived from the stimulated condition by using the wild-type ACAP1. The mean of this calculated value from three independent experi-
ments is shown with standard error.
(E) Point mutation to aspartate at S554 or S724 in ACAP1 renders its association with endosomal β1 constitutively enhanced. The same
experiment was performed as described in (D), with cells transfected with different point mutants of ACAP1 as indicated.maquine to provide a reversible block in recycling,
as done previously (Blagoveshchenskaya et al., 2002).
Cells that stably expressed the different aspartate point
mutants of ACAP1 were starved and then treated with
primaquine to allow the accumulation of antibody
bound surface β1 at the recycling endosome. We con-
firmed that primaquine did not reroute β1 to a different
endosomal compartment, because it still colocalized
with ACAP1, as assessed by confocal microscopy (Fig-
ure S2B). The recycling assay was then performed, by
using the point at which primaquine was washed away
as the initial time point. As predicted, β1 recycled in
cells that expressed either aspartate mutations of
ACAP1 even under the starvation condition (Figure 4E).
In contrast, β1 did not recycle in cells that expressed
wild-type ACAP1, a finding that also confirmed that
treatment with primaquine did not itself alter the stimu-
lation dependency of β1 recycling. Thus, we concluded
that the association of ACAP1 with endosomal β1 was
responsible for the regulated recycling of β1.
Akt Phosphorylates S554 in ACAP1
We next sought to determine more definitively whether
the effects of mutations at the two key residues in
ACAP1 were due to perturbations in their phosphoryla-
tion. For this goal, we used liquid chromatography tan-
dem mass spectrometry (LC-MS/MS) (Stemmann et
al., 2001) to target specifically on the phosphorylated
and unphosphorylated peptides harboring S554 and
S724. To analyze potential phosphorylation events in a
physiologically relevant manner, we immunoprecipi-
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ctated ACAP1 from acutely stimulated HeLa cells. LC-S/MS analysis of this ACAP1 detected both phos-
horylated and unphosphorylated tryptic peptides that
ontained the S554 residue (Figure 5A). Specifically, di-
gnostic ions that distinguished between phosphoryla-
ion at S554 and S547 in these peptides included a low-
ntensity b12 singly charged ion (m/z = 1254.7; Figure
B, inset) and a low-intensity b14 doubly charged ion
m/z = 754.4; not shown). In addition, MS3 fragmenta-
ion spectra of the doubly charged y17 ion (m/z = 966.0 ±
.5) generated during MS2 fragmentation of the phos-
hopeptide precursor measured a significant peak at
/z = 1322.6. This value correlated with the predicted
ass (m/z = 1322.8) of a singly charged b12 ion (com-
are to the singly charged b14 ion in the MS2 scan).
hus, these observations unambiguously identified S554
s a phosphorylation site on ACAP1.
However, in the same sample, we identified the un-
hosphorylated peptide containing S724 (Figure S3),
ut we did not detect the phosphorylated form of this
eptide. We ruled out technical reasons, such as phos-
horylation rendering the peptide excessively polar to
revent its detection. Thus, as we had analyzed an
CAP1 sample isolated from an in vivo condition rele-
ant for stimulation-dependent β1 recycling, we con-
luded that phosphorylation explained the effects that
e had observed (described above) in mutating S554,
ut not in mutating S724.
As corroborating evidence, we also asked which ki-
ases that may act at either S554 or S724 of ACAP1
ased on the prediction algorithm (Yaffe et al., 2001)
ould be detected to associate with ACAP1 in vivo.Candidate kinases for S554 in ACAP1 included Akt and
Integrin Recycling through ACAP1 Phosphorylation
667Figure 4. Direct Association of ACAP1 with
β1 Responsible for the Role of ACAP1 in β1
Recycling
(A) Mutations at S554 or S724 in ACAP1 do
not affect its relative distribution between
membrane and cytosol. Cell lines that stably
express different tagged forms of ACAP1
were either starved or stimulated and then
permeabilized to derive total membranes
and cytosol. Both fractions were immu-
noblotted for the tagged forms of ACAP1,
and then the membrane fraction was calcu-
lated as a percentage of the total. The mean
of this calculated value from three indepen-
dent experiments is shown with standard
error.
(B) Mutations at S554 or S724 in ACAP1 af-
fect the protein interaction between ACAP1
and β1. The different forms of ACAP1 as re-
combinant proteins were incubated with
beads that contained GST-β1, followed by
immunoblotting for ACAP1 and detection of
GST-β1 by Coomassie staining. As control,
beads that contained only GST were sub-
jected to a similar incubation. Input shows
that the levels of recombinant ACAP1 added
in different incubations were similar.
(C) Mutations at S554 or S724 in ACAP1 do
not affect the protein interaction between ACAP1 and TfR. The same pull-down experiment as described in (B) was performed, except GST-
TfR was used.
(D) Stable expression of either S554A or S724A inhibits stimulation-dependent recycling of β1. HeLa cells that stably expressed different
forms of ACAP1 as indicated, or untransfected, were subjected to the recycling assay. The level of internal β1 at the times indicated was
quantified and then calculated as a percentage of that at the initial time point. The mean of this calculated value from three independent
experiments is shown with standard error.
(E) Stable expression of either S554D or S724D induces β1 recycling even in the absence of stimulation. HeLa cells that stably expressed
different forms of ACAP1 were subjected to the recycling assay as described in (D). In this case, starved cells were also treated with
primaquine (0.3 mM) to accumulate β1 at the recycling endosome and were then assessed for β1 recycling under continual starvation when
primaquine was washed away at the times indicated.protein kinase C (PKC) isoforms α, β, γ, and ζ, while
S724 was predicted to be targeted only by casein ki-
nase 2 (CK2). In an effort to enhance the detection of
any potential interaction of the kinases with the com-
plex of ACAP1 and endosomal β1 in acutely stimulated
cells, we deliberately overexpressed each of the candi-
date kinases by transient transfection. Whereas Akt
that was predicted to act on S554 was detected in as-
sociation with endosomal β1, we did not observe signif-
icant association by the other candidate kinases (Fig-
ure 5B). Thus, we focused on characterizing how Akt
acted on ACAP1.
An antibody has been developed that recognizes a
consensus sequence of (K/R)X(K/R)XX(pS/pT) on sub-
strates phosphorylated by Akt, where either S or T must
be phosphorylated (Manning et al., 2002). Using this
antibody, previously designated as Akt-pSub antibody
(Manning et al., 2002), we found that it recognized re-
combinant wild-type ACAP1 only after incubation with
purified active Akt in an in vitro kinase assay (Figure
5C). As ACAP1 contained two residues (T461 and S554)
that are potential consensus sites for Akt, based on the
prediction algorithm, we also examined the effect of the
S554A mutation. Because the Akt-pSub antibody did
not recognize this mutant after the incubation (Figure
5C), we concluded that Akt only phosphorylated S554
in ACAP1.
Consistent with Akt acting on ACAP1, we detected
endosomal β1 to assemble with ACAP1 and Akt upon
acute stimulation in vivo, and we also found thatACAP1 in this complex was recognized by the Akt-
pSub antibody (Figure 5D). However, a potential caveat
of the results thus far using the Akt-pSub antibody was
that its recognition of ACAP1 might not reflect phos-
phorylation specifically by Akt. Thus, to provide further
evidence that S554 of ACAP1 was targeted by Akt
rather than another kinase that might recognize a sim-
ilar consensus sequence, we examined the effect of
knocking down Akt. Using a siRNA previously shown
to target sequences common to both Akt1 and Akt2
(Katome et al., 2003), we first confirmed efficient reduc-
tion of endogenous Akt in HeLa cells by this siRNA (Fig-
ure S1B). In these cells, ACAP1 was no longer recog-
nized by the Akt-pSub antibody upon acute stimulation
(Figure 6A). Moreover, immunoprecipitation of endoso-
mal β1 from these treated cells revealed that it no
longer formed a complex with ACAP1 and Akt upon
stimulation (Figure 6B), and β1 recycling in these cells
were also inhibited (Figure 6C). As Akt contributes to
cell survival, we also ruled out that the observed effects
in siRNA-treated cells were due to apoptosis (Figure
S4). Taken together, these results provided further evi-
dence that the recognition of ACAP1 by the Akt-pSub
antibody represented phosphorylation by Akt rather
than by another kinase.
Regulation of Akt Phosphorylation on ACAP1
We also sought an alternate explanation for how muta-
tions at S724 in ACAP1 affected its interaction with β1,
in light of the failure to detect its phosphorylation under
Developmental Cell
668Figure 5. Akt Phosphorylates S554 in ACAP1
(A) LC-MS/MS identifies S554 as an in vivo phosphorylation site on ACAP1. ACAP1 transiently transfected in HeLa cells that had been acutely
stimulated was immunoprecipitated and then subjected to trypsin digestion, followed by LC-MS/MS analysis, by using a method to fragment
the top ten most intense ions in each precursor scan and also a targeted method to fragment the phosphorylated and unphosphorylated pep-
tides.
(B) Akt associates with endosomal β1 in acutely stimulated cells. HeLa cells were transiently transfected with tagged forms of the different
kinases as indicated, and then endosomal β1 was immunoprecipitated, followed by immunoblotting for proteins as indicated. As control,
direct immunoblotting of whole-cell lysates (5% of total used in the immunoprecipitation studies) indicates detectable levels of different
transfected kinases.
(C) Phosphorylation of S554 in ACAP1 by Akt. Different forms of recombinant soluble ACAP1 as indicated were incubated individually with a
constitutively active form of Akt for an in vitro kinase assay. Afterwards, Western blotting was performed by using either an anti-ACAP1
antibody (indicated as ACAP1) or the Akt-pSub antibody (indicated as p-ACAP1).
(D) Acute stimulation induces ACAP1 and Akt to assemble with endosomal β1. HeLa cells were transiently transfected with different forms of
ACAP1 as indicated, and then endosomal β1 was immunoprecipitated, followed by immunoblotting for proteins as indicated.the relevant in vivo condition. In the in vitro kinase as-
say, incubation of the S724A mutant with Akt did not
result in recognition by the Akt-pSub antibody, while a
similar incubation with the S724D mutant allowed for
this recognition (Figure 5C). To provide evidence that
the observed effect of the S724A mutant was specific,
we examined two additional alanine mutants, S568A
(which is near S554A) and Y712F (which is near S724A),
and found that they were also recognized by the Akt-
pSub antibody after incubation with Akt (Figure 5C).
Thus, we concluded that the S724A mutation in ACAP1
h
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oad a specific effect in preventing Akt from acting on
he S554 site. Consistent with this explanation, the
timulation-dependent assembly of endosomal β1 with
CAP1 and Akt in stimulated cells was inhibited not
nly by the S554A mutation but also by the S724A mu-
ation (Figure 5D).
To gain insight into how intracellular signaling might
odulate the ability of Akt to act on ACAP1, we also
xamined the role of a canonical signaling pathway that
as been well characterized to regulate Akt. Activation
f Akt requires that it binds to specific phosphoinositides
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669Figure 6. A Critical Role for Phosphorylation of ACAP1 by Akt in the Assembly of an Endosomal β1 Complex that Mediates β1 Recycling
(A) Knocking down Akt abolishes phosphorylation of ACAP1 induced by acute stimulation. HeLa cells were treated with siRNA against Akt,
followed by immunoprecipitation for ACAP1 and then immunoblotting with either the anti-ACAP1 antibody or the Akt-pSub antibody.
(B) Knocking down Akt prevents the assembly of endosomal β1 with ACAP1. HeLa cells were treated with siRNA against Akt, followed by
immunoprecipitation for endosomal β1 and then immunoblotting for proteins as indicated.
(C) Knocking down Akt inhibits β1 recycling. HeLa cells treated with siRNA against Akt or a scrambled siRNA were subjected to the recycling
assay. The level of internal β1 at the times indicated was quantified and then calculated as a percentage of that at the initial time point. The
mean of this calculated value from three independent experiments is shown with standard error.
(D) The stimulation-dependent assembly of endosomal β1 with endogenous ACAP1 and Akt requires PI3K activity. HeLa cells were subjected
to different conditions as indicated, and then endosomal β1 was immunoprecipitated, followed by immunoblotting for proteins as indicated.
LY294002 was used at 50 uM.
(E) Addition of serum, EGF, or insulin enhances the interaction of endosomal β1 with ACAP1, which is blocked by inhibitors of PI3K and Akt.
HeLa cells were subjected to different conditions as indicated, and then endosomal β1 was immunoprecipitated, followed by immunoblotting
for proteins as indicated. The following concentrations were used: serum, 20%; EGF, 0.1 g/ml; insulin, 1 g/ml; LY294002, 50 M; and Akt
inhibitor, 20 M.that are the product of phosphatidylinositol 3-phosphate
kinase (PI3K), and, thus, inhibitors of PI3K activity can
be used to block Akt activity (Burgering and Coffer,
1995). When cells were first pretreated with one of
these inhibitors, LY294002, we found that acute stimu-
lation could no longer induce the formation of endoso-
mal β1 with ACAP1 and Akt (Figure 6D). Notably, this
result was observed in untransfected cells, indicating
that the previously observed complex formation for
transfected proteins (Figure 5D) also occurred for en-
dogenous proteins (Figure 6D).
We also sought to identify upstream cell surface re-
ceptors that are stimulated upon the addition of serum
in our stimulation protocol. Specific ligands that bind
either the insulin receptor or the EGF receptor have
been shown to be upstream of the PI3K/Akt signaling
pathway (Burgering and Coffer, 1995). We found that
the addition of these ligands induced the formation of
endosomal β1 with ACAP1 and Akt, and that this com-
plex formation was inhibited in the presence of either
LY294002 or another Akt inhibitor, a phosphatidylinosi-
tol analog that binds to the pleckstrin homology do-
main of Akt to inhibit its activation by phosphorylation
(Hu et al., 2000) (Figure 6E). Taken together, these re-
sults revealed that a canonical signaling pathway wellknown to regulate Akt activation was also involved in
modulating the role of Akt in regulating ACAP1.
A Critical Role for ACAP1, Akt, and Their Assembly
with Endosomal 1 in Cell Migration
Finally, as integrin recycling and Akt have both been
implicated in cell migration (Brazil and Hemmings,
2001; Webb et al., 2002), we tested whether perturbing
the ability of Akt to act on ACAP1 in modulating β1 re-
cycling would affect cell migration. For this purpose,
we examined two assays of cell migration. In one assay,
migration was measured across Transwell membrane
coated with fibronectin to assess β1-dependent move-
ment, as HeLa cells express mainly β1 integrins to me-
diate adhesion to this matrix substance (Shaw et al.,
1995). Initially, examining the roles of Akt (Figure 7A)
and ACAP1 (upper panel of Figure 7B), we found that
cells treated with siRNA against either target inhibited
migration. Subsequently, to disrupt more specifically
the association of endosomal β1 with ACAP1, we ex-
amined HeLa cells that stably expressed either the
S554A or the S724A point mutants, and we found that
these cells also exhibited reduced cell migration (Figure
7C). Confirming these results by a different migration
assay that examines wound healing, we found that
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Their Assembly into an Endosomal Complex
with β1 in Cell Migration
(A) Knocking down Akt inhibits migration
across Transwell membrane coated with fi-
bronectin. HeLa cells treated with siRNA
against Akt or a scrambled siRNA were ex-
amined in a migration assay across Transwell
membrane coated with fibronectin. The num-
ber of migrating cells was compared to the
condition of no treatment and then ex-
pressed as a percentage. The mean with
standard error was then derived from three
independent experiments.
(B) Knocking down ACAP1 inhibits migration
across Transwell membrane coated with fi-
bronectin. (Upper panel) HeLa cells trans-
fected with a plasmid that expressed siRNA
against ACAP1, or a scrambled siRNA, or not
transfected were examined in a migration
assay across Transwell membrane coated
with fibronectin. The results are expressed
as described in (A). (Bottom panel) HeLa
cells that stably expressed a rescue form of
ACAP1 were examined by the same experi-
ment described in the upper panel.
(C) Expression of either the S554A or the
S724A mutant inhibits migration across Trans-
well membrane coated with fibronectin. HeLa
cells that stably expressed the different point
mutants of ACAP1 as indicated were exam-
ined in a migration assay across Transwell
membrane coated with fibronectin. The results
were expressed as described in (A).
(D) Knocking down Akt inhibits wound-heal-
ing migration. HeLa cells treated with siRNA
against Akt or a scrambled siRNA were ex-
amined in the wound-healing assay. Results
are representative of three independent ex-
periments.
(E) Knocking down ACAP1 inhibits wound-
healing migration. (Upper panel) HeLa cells
transfected with a plasmid that expressed
siRNA against ACAP1, or a scrambled siRNA,
or not transfected were examined in the
wound-healing assay. (Bottom panel) HeLa
cells that stably expressed a rescue form of
ACAP1 were examined by the same experi-
ment described in the upper panel. Both re-
sults are representative of three indepen-
dent experiments.
(F) Expression of either the S554A or the S724A mutant inhibits wound-healing migration. HeLa cells that stably expressed the different point
mutants of ACAP1 as indicated were examined in the wound-healing assay. Results are representative of three independent experiments.siRNA against Akt (Figure 7D) or ACAP1 (upper panel
of Figure 7E), or the ectopic expression of the S554A
or the S724A mutant of ACAP1 (Figure 7F), also inhib-
ited cell migration. Moreover, in both migration assays,
we confirmed the specificity of the siRNA against
ACAP1, as the stable expression of the rescue con-
struct reversed the effects seen by the treatment of
siRNA against endogenous ACAP1 (lower panels of
Figures 7B and 7E).
Discussion
We have elucidated how ACAP1 functions in the regu-
lated recycling of integrin β1. Taking advantage of the
previous insight that ACAP1 functions not only as a
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GAP for ARF6, but also as its effector in cargo sortingDai et al., 2004), we first show that ACAP1 associates
ith β1 at the recycling endosome in a stimulation-
ependent manner. Investigating how external stimula-
ion regulates this association, we identify two key resi-
ues in ACAP1 and then elucidate their roles. For S554,
ts role is due to phosphorylation by Akt, which is, in
urn, regulated by a canonical signaling pathway insti-
ated by surface growth factor receptors. For S724, our
indings suggest an alternate mechanism that modu-
ates the ability of ACAP1 to be engaged by Akt at the
554 site (which will be discussed in more detail be-
ow). These observations then allowed us to show that
he assembly of ACAP1 and Akt with endosomal β1 me-
iates β1 recycling during cell migration.
Besides having identified a key transport effector
hat represents the ultimate downstream target in integ-
rin recycling, our findings also contribute to a general
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671understanding of how a transport effector can mediate
both constitutive and regulated transport, as we pro-
vide a mechanistic explanation for how ACAP1 is able
to participate in the cargo sorting of both constitutively
recycling proteins and regulated recycling proteins. In
this explanation, we have provided an unexpected in-
sight. Initial analysis of how mutations at two key resi-
dues in ACAP1 affect its association with β1 reveals
similar effects, leading to the impression that both resi-
dues would exert their roles through phosphorylation
at these sites. However, using mass spectrometry to
identify phosphorylation sites more definitively, we de-
tect phosphorylation only at S554, when ACAP1 is iso-
lated from an in vivo condition relevant for β1 recycling.
Thus, while the mutational effects at S554 are explained
by phosphorylation at this site, the mutational effects
at S724 require an alternate mechanism.
In considering a plausible explanation, we are led by
the consideration that mutation from serine to aspar-
tate should render a residue more hydrophilic, while
mutation from serine to alanine should have the oppo-
site effect of causing the residue to be more hydropho-
bic. Thus, an intriguing possibility is that serine at posi-
tion 724 supports a conformation of ACAP1 that is
intermediate in the spectrum of two extremes, with one
end being a conformation that would result in a high-
affinity interaction between ACAP1 and β1 (represented
by the effect of mutating to aspartate) and the other
end being a conformation that would result in either
no or low-affinity interaction between ACAP1 and β1
(represented by the effect of mutating to alanine). Such
a mechanism would also readily explain some key ob-
servations that we have made. First, one can readily
envision how phosphorylation at S554 in ACAP1 would
regulate a change in the conformation of ACAP1 to
modulate its interaction with β1. Second, one can envi-
sion a conformational change in ACAP1 that is suffi-
ciently global so that it affects not only binding to β1,
but also access to its S554 site by Akt. This scenario
can, in turn, explain why mutation at S724 affects phos-
phorylation of S554 by Akt, and also why single muta-
tions at either S554 or S724 would have a dominant
effect on the association of ACAP1 with β1.
Finally, we note that an important implication of our
cumulative findings on ACAP1 as a cargo-sorting de-
vice is that this role will be relevant for a broad range
of cellular activities that are known to involve endocytic
recycling. Besides cell migration, which itself underlies
a wide range of physiologic and pathologic events,
other important examples that require endocytic recycl-
ing include insulin-stimulated recycling of glucose trans-
porters, cell polarity, cytokinesis, and phagocytosis.
Thus, the future investigation of a potential role for
ACAP1 in these examples will likely contribute to a bet-
ter mechanistic understanding of how these events
are achieved.
Experimental Procedures
Reagents and Cells
Reagents obtained include: EGF, insulin, biotinylated transferrin,
and LY294002 (all from Sigma; St. Louis, MO), and the Akt inhibitor,
1L-6-hydroxymethyl-chiro-inositol [2-(R)-2-O-methyl]-3-O-octa-
decylcarbonate (from Calbiochem; La Jolla, CA). HeLa cells were
cultured as previously described (Dai et al., 2004).Antibodies
Antibodies have been described previously (Dai et al., 2004; Jack-
son et al., 2000; Powelka et al., 2004), and they include: TS2/16
against β1 integrin, W6/32 against MHC I, M3A5 against β-COP,
H68.4 against TfR, 9E10 against the Myc epitope, 15E6 against
C-terminally-tagged HA epitope, M2 against the FLAG epitope, an-
tiserum against ACAP1 peptide, antiserum against ACAP1 whole
protein, antiserum against cellubrevin, and secondary antibodies
conjugated to Cy2 or Cy3.
Additional antibodies used include: DM1α against α-tubulin
(Sigma; St. Louis, MO), the Akt-pSub antibody (Cell Signaling Tech-
nology; Beverly, MA), and antisera against Akt, the CK2-β subunit,
and PKC (recognizing all isoforms) (all from Santa Cruz Biotechnol-
ogy; Santa Cruz, CA).
Plasmids and Transfections
Flag-tagged ACAP1 in pFlag-CMV2 has been described (Jackson
et al., 2000). The following plasmids were obtained: PKCα, PKCβ,
Flag-tagged PKCγ, and Myc-tagged PKCζ (from A. Newton, Univer-
sity of California, San Diego, CA), HA-tagged Akt and the constitu-
tively active myristoylated Akt (from M. Birnbaum, University of
Pennsylvania, Philadelphia, PA), and CK2 α, α#, and β subunits
(from D. Litchfield, University of Western Ontario, London, On-
tario, Canada).
Myc-tagged ACAP1 in pcDNA 3.1 was generated by subcloning
the coding sequence of ACAP1, which was generated through the
polymerase chain reaction. Point mutants and the rescue form
(generated by mutating the nucleotides 276–279 in the siRNA-tar-
geted DNA sequence of ACAP1 from CAGC to TTCG) of ACAP1
were generated by using QuickChange XL Site-Directed Mutagene-
sis (Strategene; La Jolla, CA). To append the cytoplasmic domain
of β1 to the carboxy terminus of GST, the cDNA encoding different
domains was amplified by PCR, and then subcloned into the
BamH1 and EcoRI sites of the pGEX-4T-3 vector (Amersham Phar-
macia Biotech; Piscataway, NJ).
Transient transfections were performed by using Fugene 6
(Roche Biochemicals; Indianapolis, IN). HeLa cell lines that stably
express the different forms of ACAP1 were generated by transient
transfection, followed by selection in 1 mg/ml G418 (Life Technol-
ogies, Inc.; Gaithersburg, MD).
siRNA
Expression of siRNA against ACAP1 with the pSUPER plasmid has
been described (Dai et al., 2004). For siRNA against Akt, a se-
quence (TGCCCTTCTACAACCAGGA) that is common to both Akt1
(nucleotides 1040–1058) and Akt2 (nucleotides 1043–1061) (Ka-
tome et al., 2003), along with a scrambled sequence as control,
were obtained (Ambion; Austin, TX), and then transfected with Oli-
gofactamine (Invitrogen; Carlsbad, CA).
Confocal Microscopy
Colocalization studies were done as previously described (Dai et
al., 2004).
1 Recycling Assay
The endocytic recycling of β1 was assessed by using a previously
established biochemical assay for recycling proteins (Blagoveshchen-
skaya et al., 2002), which was adapted to examine β1 recycling as
previously described (Powelka et al., 2004). Unless indicated other-
wise, stimulation was performed by adding 20% serum to cells that
had been starved overnight.
Immunoprecipitation of Endosomal 1
Immunoprecipitation of endosomal β1 was performed as follows.
Surface β1 bound to the anti-β1 antibody TS2/16 was accumulated
at the recycling endosome in starved cells as previously described
(Powelka et al., 2004). Cells were then either continued in starvation
or acutely stimulated for 2 min with 20% serum (or specific agent
as stated otherwise), cooled to 4°C, followed by lysis in a Triton
buffer (consisting of 1% Triton X-100, 20 mM Tris [pH 7.4], and 300
mM NaCl) and incubation with Sepharose beads coated with pro-
tein A (Amersham Pharmacia Biotech; Piscataway, NJ). Beads were
then washed three times with the Triton lysis buffer and analyzed
by SDS-PAGE under nonreducing conditions.
Developmental Cell
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Pull-down assays were performed essentially as previously de-
scribed (Dai et al., 2004), except different forms of recombinant
ACAP1 were expressed as myc-tagged proteins by using the TNT
T7 coupled reticulocyte lysate system (Promega; Madison, WI), and
then purified by binding to anti-myc antibody on beads, followed
by elution from beads by adding excess soluble myc peptide
(Sigma; St. Louis, MO).
In Vitro Kinase Assay
The in vitro kinase assay was performed essentially as previously
described (Zheng et al., 2000). Recombinant forms of purified
ACAP1 were first dephosphorylated with calf intestinal phospha-
tase prior to use in the kinase assay. Because Akt requires multiple
phosphorylation for its activation (Brazil and Hemmings, 2001), we
purified active Akt by transfecting a construct that encodes an HA-
tagged form of a constitutively active Akt (by the addition of a my-
ristoylation signal [Kohn et al., 1996]) in Hela cells, followed by im-
munoprecipitation with an anti-HA antibody.
Orthophosphate Labeling
HeLa cells were starved overnight in DMEM with 0.01% bovine se-
rum albumin (BSA, Sigma; St. Louis, MO), followed by incubation
in 1 ml of the same medium with 2 mCi 32P-labeled ATP added for
each 100 mm plate at 37°C for 2 hr. Cells were then stimulated with
20% serum that had been prewarmed to 37°C. At different time
points as indicated, cells were lysed in the Triton buffer with phos-
phatase inhibitors (1 mM sodium orthovanadate, 1 mM sodium
fluoride, 10 mM β-glycerophosphate) for analysis by immunopre-
cipitation as described above.
LC-MS/MS
The general procedure was performed as previously described
(Ballif et al., 2005). Digestion was allowed to proceed for 100 min
at 37°C. Longer digests resulted in cleavage C-terminal to Arg at
Arg-Pro sites near S554 and made even the unphosphorylated form
of the peptide harboring S554 undetectable. Precursor scans were
performed in the FTICR cell at 100,000 resolution and an AGC set-
ting of two million. Targeted MS2 scans (m/z = 706.1 ± 1.5 and
m/z = 679.4 ± 1.5) and a targeted MS3 scan (m/z = 966.0 ± 1.5
generated from fragmentation of the 706.1 precursor) were per-
formed in the ion trap mass spectrometer by using one microscan
and a 500 ms fill time. MS2 spectra were searched against the pro-
tein sequence for human ACAP1 by using SEQUEST and a mass
tolerance of 1.1 Da with no enzyme specificity.
Apoptosis Assay
Cells were stained with PE-conjugated Annexin V according to the
manufacturer’s protocol for adherent cells (BD Pharmingen; San
Diego, CA).
Migration Assays
Migration across membrane in a Transwell chamber (6.5 mm insert
diameter, 8 m pore size, polycarbonate membrane; Corning
Glassworks; Corning, NY) was assessed by first coating both sides
of the membrane with 10 g/ml fibronectin in PBS overnight at 4°C
and then blocked with 1% BSA in DMEM for 1 hr at 37°C. Cells
starved in DMEM with 0.01% BSA were then stimulated by adding
20% fetal bovine serum, were then plated (1 × 105 cells in 100 l)
to the top chamber, and were allowed to migrate for 4 hr at 37°C.
Membranes were fixed in 4% paraformaldehyde for 15 min. Cells
remaining on the top side of the membrane were removed by using
a cotton swab. The remaining cells on the bottom side were stained
with propidium iodide (Sigma; St. Louis, MO) and then counted by
using fluorescence microscopy with a 10× objective of a Nikon Op-
tiphot2 microscope (Nikon Instruments; Melville, NY).
For the wound-healing migration assay, confluent cells on cover-
slips were starved overnight in DMEM with 0.01% BSA. After mar-
ring coverslips with a linear scratch by a sterile pipette tip, cells
were stimulated with 20% fetal bovine serum at 37°C for the times
indicated. Images were taken with the 4× objective of a Nikon
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ng knockdown by siRNA, distribution of ACAP1 mutants by immu-
ofluorescence microscopy, mass spectrometry of the ACAP1 pep-
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cknowledgments
e thank Stella Lee, Jia-Shu Yang, Leiliang Zhang, and Richard
remont for advice and discussions; Huiya Gilbert and Hans Kiener
or technical assistance; and Jonathan Higgins, Alberto Luini, Sanja
ever, and Sheila Thomas for critical comments on the manuscript.
his work was funded in part by grants to V.W.H. (American Heart
ssociation, Massachusetts Department of Public Health, and the
ational Institutes of Health [NIH]), J.L. (Department of Defense
reast Cancer Research Program), and S.P.G. (NIH Grant HG00041).
eceived: April 20, 2005
evised: August 24, 2005
ccepted: September 22, 2005
ublished: October 31, 2005
eferences
allif, B.A., Roux, P.P., Gerber, S.A., MacKeigan, J.P., Blenis, J., and
ygi, S.P. (2005). Quantitative phosphorylation profiling of the ERK/
90 ribosomal S6 kinase-signaling cassette and its targets, the tu-
erous sclerosis tumor suppressors. Proc. Natl. Acad. Sci. USA
02, 667–672.
lagoveshchenskaya, A.D., Thomas, L., Feliciangeli, S.F., Hung,
.H., and Thomas, G. (2002). HIV-1 Nef downregulates MHC-I by a
ACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111,
53–866.
razil, D.P., and Hemmings, B.A. (2001). Ten years of protein kinase
signalling: a hard Akt to follow. Trends Biochem. Sci. 26, 657–664.
retscher, M.S. (1992). Circulating integrins: α 5 β 1, α 6 β 4 and
ac-1, but not α 3 β 1, α 4 β 1 or LFA-1. EMBO J. 11, 405–410.
urgering, B.M., and Coffer, P.J. (1995). Protein kinase B (c-Akt) in
hosphatidylinositol-3-OH kinase signal transduction. Nature 376,
99–602.
ai, J., Li, J., Bos, E., Porcionatto, M., Premont, R.T., Bourgoin,
., Peters, P.J., and Hsu, V.W. (2004). ACAP1 promotes endocytic
ecycling by recognizing recycling sorting signals. Dev. Cell 7,
71–776.
u, Y., Qiao, L., Wang, S., Rong, S.B., Meuillet, E.J., Berggren, M.,
allegos, A., Powis, G., and Kozikowski, A.P. (2000). 3-(Hydroxy-
ethyl)-bearing phosphatidylinositol ether lipid analogues and car-
onate surrogates block PI3-K, Akt, and cancer cell growth. J.
ed. Chem. 43, 3045–3051.
vaska, J., Whelan, R.D.H., Watson, R., and Parker, P.J. (2002).
KC- controls the traffic of β1 integrins in motile cells. EMBO J.
1, 3608–3619.
ackson, T.R., Brown, F.D., Nie, Z., Miura, K., Foroni, L., Sun, J.,
su, V.W., Donaldson, J.G., and Randazzo, P.A. (2000). ACAPs are
rf6 GTPase-activating proteins that function in the cell periphery.
. Cell Biol. 151, 627–638.
atome, T., Obata, T., Matsushima, R., Masuyama, N., Cantley, L.C.,
otoh, Y., Kishi, K., Shiota, H., and Ebina, Y. (2003). Use of RNA
nterference-mediated gene silencing and adenoviral overexpres-
ion to elucidate the roles of AKT/protein kinase B isoforms in insu-
in actions. J. Biol. Chem. 278, 28312–28323.
ohn, A.D., Takeuchi, F., and Roth, R.A. (1996). Akt, a pleckstrin
omology domain containing kinase, is activated primarily by
hosphorylation. J. Biol. Chem. 271, 21920–21926.
Integrin Recycling through ACAP1 Phosphorylation
673Kuehn, M.J., Herrmann, J.M., and Schekman, R. (1998). COPII-
cargo interactions direct protein sorting into ER-derived transport
vesicles. Nature 391, 187–190.
Lawson, M.A., and Maxfield, F.R. (1995). Calcium- and calcineurin-
dependent cycling of an integrin to the front of migrating neutro-
phils. Nature 377, 75–79.
Manning, B.D., Tee, A.R., Logsdon, M.N., Blenis, J., and Cantley,
L.C. (2002). Identification of the tuberous sclerosis complex-2 tu-
mor suppressor gene product tuberin as a target of the phospho-
inositide 3-kinase/akt pathway. Mol. Cell 10, 151–162.
Ng, T., Shima, D., Squire, A., Bastiaens, P.I., Gschmeissner, S.,
Humphries, M.J., and Parker, P.J. (1999). PKCα regulates β1 integ-
rin-dependent cell motility through association and control of in-
tegrin traffic. EMBO J. 18, 3909–3923.
Nie, Z., Hirsch, D.S., and Randazzo, P.A. (2003). Arf and its many
interactors. Curr. Opin. Cell Biol. 15, 396–404.
Powelka, A.M., Sun, J., Li, J., Gao, M., Shaw, L.M., Sonnenberg, A.,
and Hsu, V.W. (2004). Stimulation-dependent recycling of integrin
β1 regulated by ARF6 and Rab11. Traffic 5, 20–36.
Roberts, M.S., Woods, A.J., Dale, T.C., Van Der Sluijs, P., and Nor-
man, J.C. (2004). Protein kinase B/Akt acts via glycogen synthase
kinase 3 to regulate recycling of α v β 3 and α 5 β 1 integrins. Mol.
Cell. Biol. 24, 1505–1515.
Shaw, S., Luce, G.G., Gilks, W.R., Anderson, K., Ault, K., Bochner,
B.S., Boumsell, L., Denning, S.M., Engleman, E.G., Fleisher, T., et
al. (1995). Leucocyte differentiation antigen database. In Leukocyte
Typing V: Proceedings of the Fifth International Workshop and Con-
ference, S.F. Schlossman, L. Boumsell, W. Gilks, J.M. Harlan, T. Ki-
shimoto, C. Morimoto, J. Ritz, S. Shaw, R. Silverstein, and S.
Springer, et al., eds. (Oxford, UK: Oxford University Press), pp.
16–198.
Stemmann, O., Zou, H., Gerber, S.A., Gygi, S.P., and Kirschner,
M.W. (2001). Dual inhibition of sister chromatid separation at meta-
phase. Cell 107, 715–726.
Webb, D.J., Parsons, J.T., and Horwitz, A.F. (2002). Adhesion as-
sembly, disassembly and turnover in migrating cells - over and over
and over again. Nat. Cell Biol. 4, E97–E100.
Woods, A.J., White, D.P., Caswell, P.T., and Norman, J.C. (2004).
PKD1/PKCmicro promotes αvβ3 integrin recycling and delivery to
nascent focal adhesions. EMBO J. 23, 2531–2543.
Yaffe, M.B., Leparc, G.G., Lai, J., Obata, T., Volinia, S., and Cantley,
L.C. (2001). A motif-based profile scanning approach for genome-
wide prediction of signaling pathways. Nat. Biotechnol. 19, 348–
353.
Yang, J.S., Lee, S.Y., Gao, M., Bourgoin, S., Randazzo, P.A., Pre-
mont, R.T., and Hsu, V.W. (2002). ARFGAP1 promotes the formation
of COPI vesicles, suggesting function as a component of the coat.
J. Cell Biol. 159, 69–78.
Zheng, W.H., Kar, S., and Quirion, R. (2000). Stimulation of protein
kinase C modulates insulin-like growth factor-1-induced akt activa-
tion in PC12 cells. J. Biol. Chem. 275, 13377–13385.
